Cargando…
Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484722/ https://www.ncbi.nlm.nih.gov/pubmed/35878877 http://dx.doi.org/10.1021/acschembio.2c00545 |
_version_ | 1784791936224198656 |
---|---|
author | Graves, Paul R. Aponte-Collazo, Lucas J. Fennell, Emily M. J. Graves, Adam C. Hale, Andrew E. Dicheva, Nedyalka Herring, Laura E. Gilbert, Thomas S. K. East, Michael P. McDonald, Ian M. Lockett, Matthew R. Ashamalla, Hani Moorman, Nathaniel J. Karanewsky, Donald S. Iwanowicz, Edwin J. Holmuhamedov, Ekhson Graves, Lee M. |
author_facet | Graves, Paul R. Aponte-Collazo, Lucas J. Fennell, Emily M. J. Graves, Adam C. Hale, Andrew E. Dicheva, Nedyalka Herring, Laura E. Gilbert, Thomas S. K. East, Michael P. McDonald, Ian M. Lockett, Matthew R. Ashamalla, Hani Moorman, Nathaniel J. Karanewsky, Donald S. Iwanowicz, Edwin J. Holmuhamedov, Ekhson Graves, Lee M. |
author_sort | Graves, Paul R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9484722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94847222022-09-20 Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues” Graves, Paul R. Aponte-Collazo, Lucas J. Fennell, Emily M. J. Graves, Adam C. Hale, Andrew E. Dicheva, Nedyalka Herring, Laura E. Gilbert, Thomas S. K. East, Michael P. McDonald, Ian M. Lockett, Matthew R. Ashamalla, Hani Moorman, Nathaniel J. Karanewsky, Donald S. Iwanowicz, Edwin J. Holmuhamedov, Ekhson Graves, Lee M. ACS Chem Biol American Chemical Society 2022-07-25 2022-08-19 /pmc/articles/PMC9484722/ /pubmed/35878877 http://dx.doi.org/10.1021/acschembio.2c00545 Text en © 2022 American Chemical Society https://pubs.acs.org/page/policy/authorchoice_termsofuse.htmlThis is an open access article published under an ACS AuthorChoice License (https://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Graves, Paul R. Aponte-Collazo, Lucas J. Fennell, Emily M. J. Graves, Adam C. Hale, Andrew E. Dicheva, Nedyalka Herring, Laura E. Gilbert, Thomas S. K. East, Michael P. McDonald, Ian M. Lockett, Matthew R. Ashamalla, Hani Moorman, Nathaniel J. Karanewsky, Donald S. Iwanowicz, Edwin J. Holmuhamedov, Ekhson Graves, Lee M. Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title | Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title_full | Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title_fullStr | Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title_full_unstemmed | Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title_short | Correction to
“Mitochondrial Protease ClpP
Is a Target for the Anticancer Compounds ONC201 and Related Analogues” |
title_sort | correction to
“mitochondrial protease clpp
is a target for the anticancer compounds onc201 and related analogues” |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484722/ https://www.ncbi.nlm.nih.gov/pubmed/35878877 http://dx.doi.org/10.1021/acschembio.2c00545 |
work_keys_str_mv | AT gravespaulr correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT apontecollazolucasj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT fennellemilymj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT gravesadamc correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT haleandrewe correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT dichevanedyalka correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT herringlaurae correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT gilbertthomassk correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT eastmichaelp correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT mcdonaldianm correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT lockettmatthewr correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT ashamallahani correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT moormannathanielj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT karanewskydonalds correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT iwanowiczedwinj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT holmuhamedovekhson correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues AT gravesleem correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues |